Clinical Trial Update: Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System [NA]

View source ↗

Summary

This document reports the completion and results posting of the Nucleus Hybrid L24 Cochlear Implant System clinical trial for sensorineural hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• Nucleus Hybrid L24 Cochlear Implant System

Snippet

Sponsor: Cochlear | Conditions: Sensorineural Hearing Loss | NA | Status: COMPLETED | Results posted: 2014-09-29